Inspire Medical Systems Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Inspire Medical Systems stock.
View analyst ratings for Inspire Medical Systems or view top-rated stocks.

Wall Street analysts have given Inspire Medical Systems a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Inspire Medical Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Inspire Medical Systems is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Inspire Medical Systems.

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Tuesday, February, 23rd. The company reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.45) by $0.17. The company earned $46.01 million during the quarter, compared to analyst estimates of $39.20 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 32.23% and a negative net margin of 61.07%. The company's quarterly revenue was up 71.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.38) earnings per share.
View Inspire Medical Systems' earnings history.

Inspire Medical Systems' stock was trading at $75.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, INSP stock has increased by 146.9% and is now trading at $186.77.
View which stocks have been most impacted by COVID-19.

Inspire Medical Systems updated its FY 2021 After-Hours earnings guidance on Tuesday, February, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $183-188 million, compared to the consensus revenue estimate of $171.65 million.

11 Wall Street analysts have issued 12 month price objectives for Inspire Medical Systems' shares. Their forecasts range from $50.00 to $275.00. On average, they expect Inspire Medical Systems' stock price to reach $168.55 in the next year. This suggests that the stock has a possible downside of 9.8%.
View analysts' price targets for Inspire Medical Systems or view top-rated stocks among Wall Street analysts.

2 employees have rated Inspire Medical Systems CEO Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among Inspire Medical Systems' employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Inspire Medical Systems include Teleflex (TFX), Insulet (PODD), NovoCure (NVCR), Abiomed (ABMD), Penumbra (PEN), Hill-Rom (HRC), Globus Medical (GMED), Haemonetics (HAE), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Nevro (NVRO), Inari Medical (NARI), ICU Medical (ICUI), Glaukos (GKOS) and iRhythm Technologies (IRTC).
View all of INSP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Square (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Inspire Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.40%), Credit Suisse AG (2.32%), Lord Abbett & CO. LLC (2.24%), William Blair Investment Management LLC (1.96%), Federated Hermes Inc. (1.55%) and Victory Capital Management Inc. (1.50%). Company insiders that own Inspire Medical Systems stock include Casey M Tansey, Chau Quang Khuong, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Mudit K Jain, Orbimed Advisors Llc, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends for Inspire Medical Systems.

INSP stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Victory Capital Management Inc., Pura Vida Investments LLC, Lord Abbett & CO. LLC, Frontier Capital Management Co. LLC, Voloridge Investment Management LLC, Castleark Management LLC, and UBS Asset Management Americas Inc.. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Chau Quang Khuong, Marilyn C Nelson, Orbimed Advisors Llc, Randy Ban, Richard Buchholz, Steven Jandrich, and Timothy P Herbert.
View insider buying and selling activity for Inspire Medical Systems or view top insider-selling stocks.

INSP stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Norges Bank, Credit Suisse AG, Price T Rowe Associates Inc. MD, BlackRock Inc., First Trust Advisors LP, Artisan Partners Limited Partnership, and Engineers Gate Manager LP.
View insider buying and selling activity for Inspire Medical Systems or or view top insider-buying stocks.

Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INSP stock can currently be purchased for approximately $186.77.

Inspire Medical Systems has a market capitalization of $5.07 billion and generates $82.05 million in revenue each year. The company earns $-33,240,000.00 in net income (profit) each year or ($1.40) on an earnings per share basis.

Inspire Medical Systems employs 239 workers across the globe.

The official website for Inspire Medical Systems is www.inspiresleep.com.

Inspire Medical Systems is headquartered at 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416.

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company can be reached via phone at 844-672-4357 or via email at [email protected]